CEL-SCI’s Multikine Cancer Drug May Launch in Saudi Arabia by 2025
May 21, 2025
Saudi Food and Drug Authority typically responds to Breakthrough Medicine Designation applications within approximately 60 days CEL-SCI Corporation announced it has completed its Breakthrough Medicine Designation